TrialJournal of atherosclerosis and thrombosis2017

Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin.

Fumitaka Okajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.